TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15015000

Group type: EXPERIMENTAL
Intervention: Skin cooling with a warm core of 39.5 degrees C
Number of subjects: 20

Group type: COMPARATOR
Intervention: Passive warming to rectal temperature of 39.5 degrees C
Number of subjects: 20
Study: 11606169

Group type: COMPARATOR
Intervention: Euglycaemia (blood glucose approximately 6 mmol/l)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Hyperglycaemia (blood glucose approximately 14 mmol/l)
Number of subjects: 16
Study: 9875586

Group type: EXPERIMENTAL
Intervention: Intervention (14-session face-to-face HIV risk-reduction intervention emphasizing abstinence and safer sexual practices)
Number of subjects: 515

Group type: COMPARATOR
Intervention: Control
Number of subjects: 515
Study: 8033186

Group type: EXPERIMENTAL
Intervention: 0.5 mg/ml Oolong tea extract (OTE) solution in 0.2% ethanol before and after every intake of food and before sleeping at night
Number of subjects: 35

Group type: COMPARATOR
Intervention: 0.2% ethanol without OTE for mouthrinsing
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 0.5 mg/ml Oolong tea extract (OTE) solution
Number of subjects: 35
Study: 2756357

Group type: EXPERIMENTAL
Intervention: Clindamycin and gentamicin (administered preoperatively as a single bolus infusion)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo (administered preoperatively as a single bolus infusion)
Number of subjects: 168
Study: 791330

Group type: EXPERIMENTAL
Intervention: labetalol (average daily dose about 600 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: labetalol
Number of subjects: 19
Study: 31448635

Group type: EXPERIMENTAL
Intervention: Phone coaching
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-study
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group coaching
Number of subjects: 0
Study: 31482360

Group type: EXPERIMENTAL
Intervention: Low-residue diet (LRD)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Clear liquid diet (CLD)
Number of subjects: 205
Study: 31395306

Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Baduanjin
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Stationary cycling
Number of subjects: 140

Group type: COMPARATOR
Intervention: Health education control
Number of subjects: 140
Study: 28151543

Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 8240

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 8240
Study: 25579875

Group type: EXPERIMENTAL
Intervention: Donning devices with CS40-o-t
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Donning devices with CS40-c-t
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Donning devices with CS20+20-o-t
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Donning devices with CS20+20-c-t
Number of subjects: 40

Group type: COMPARATOR
Intervention: Without donning devices with CS40-c-t
Number of subjects: 40

Group type: COMPARATOR
Intervention: Without donning devices with CS20+20-c-t
Number of subjects: 40
Study: 23944206

Group type: EXPERIMENTAL
Intervention: Plasma filtration
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 48
Study: 21592324

Group type: EXPERIMENTAL
Intervention: Multifaceted program conducted by a mobile geriatric team including geriatric preoperative consultation, training of surgical staff, implementation of the Hospital Elder Life Program, and morbidity and mortality conference related to delirium cases.
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control arm (standard care)
Number of subjects: 360
Study: 18473792

Group type: EXPERIMENTAL
Intervention: DG17 with sodium bicarbonate solution
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: DG17 with low-dose ritonavir
Number of subjects: 6

Group type: COMPARATOR
Intervention: DG17 without ritonavir
Number of subjects: 6
Study: 17194247

Group type: EXPERIMENTAL
Intervention: Slow-velocity training (SVT) at 30 degrees .s(‐1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fast-velocity training (FVT) at 270 degrees .s(‐1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 30
Study: 14738208

Group type: EXPERIMENTAL
Intervention: Diesel exhaust exposure (100 microg/m3 PM10) for 2 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Air exposure (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diesel exhaust exposure (100 microg/m3 PM10) for 2 hours in subjects with asthma
Number of subjects: 0
Study: 10793595

Group type: COMPARATOR
Intervention: PhysioFlex group (closed system)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Modulus group (low-flow system)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 16
Study: 8746333

Group type: EXPERIMENTAL
Intervention: Sodium lauryl sulphate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Benzalkonium chloride
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonanoic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Transepidermal water loss
Number of subjects: 0
Study: 1384898

Group type: EXPERIMENTAL
Intervention: Cytotoxic/G-CSF mobilization
Number of subjects: 68

Group type: COMPARATOR
Intervention: Cytotoxic mobilization
Number of subjects: 68
Study: 3909332

Group type: EXPERIMENTAL
Intervention: Aztreonam plus vancomycin (AV)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Aztreonam plus vancomycin and amikacin (AVA)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Moxalactam plus ticarcillin (MT)
Number of subjects: 170
Study: 31026084

Group type: EXPERIMENTAL
Intervention: Ipragliflozin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ipragliflozin in T2DM patients with moderate renal impairment
Number of subjects: 0
Study: 29389579

Group type: EXPERIMENTAL
Intervention: Ankascin 568 plus (500 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 26995799

Group type: EXPERIMENTAL
Intervention: SoluMatrix diclofenac 35 mg
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: SoluMatrix diclofenac 18 mg
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Celecoxib 400 mg loading dose followed by 200 mg twice daily
Number of subjects: 428

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 428
Study: 23970645

Group type: EXPERIMENTAL
Intervention: Polyactin A for 3 months
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study: 22892735

Group type: EXPERIMENTAL
Intervention: 2.5 mL 1% peracetic acid (PAA)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 2.5 mL 17% EDTA
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 2.5 mL 2.5% NaOCl + 2.5 mL 17% EDTA
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 2.5 mL 0.5% PAA
Number of subjects: 48

Group type: COMPARATOR
Intervention: Positive control group
Number of subjects: 48

Group type: COMPARATOR
Intervention: Negative control group
Number of subjects: 48
Study: 20424084

Group type: EXPERIMENTAL
Intervention: Video-game system immediately
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (video-game system after follow-up assessment)
Number of subjects: 0
Study: 18460399

Group type: EXPERIMENTAL
Intervention: Teeth brushing alone
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Teeth brushing plus tongue scraping
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Teeth brushing plus tongue cleaning using a high speed vacuum ejector and irrigation with 20 ml antibacterial mouthwash
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Daily tongue scraping
Number of subjects: 19
Study: 15798323

Group type: EXPERIMENTAL
Intervention: Stabilization method applied to coronary angiograms
Number of subjects: 41
Study: 12451982

Group type: EXPERIMENTAL
Intervention: Tablet Tongmaijiangzhi (TTMJZ) 4 tablets, tid for 8 weeks
Number of subjects: 65

Group type: COMPARATOR
Intervention: Zocor 5 mg, qd for 8 weeks
Number of subjects: 65
Study: 10613415

Group type: EXPERIMENTAL
Intervention: 117 mg/day of vitamin C during repletion phase
Number of subjects: 68

Group type: COMPARATOR
Intervention: 9 mg/day of vitamin C during depletion phase
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Body weight as a factor
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: First repletion phase
Number of subjects: 68
Study: 7655259

Group type: EXPERIMENTAL
Intervention: HNE Huntleigh's Vaperm pressure-reducing cushion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HNE Huntleigh's Multitec pressure-reducing cushion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HNE Huntleigh's Supatec pressure-reducing cushion
Number of subjects: 0
Study: 1936788

Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 0
Study: 7081116

Group type: EXPERIMENTAL
Intervention: Test diet (49.67 mg tin daily)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control diet (0.11 mg tin daily)
Number of subjects: 8
Study: 30256710

Group type: EXPERIMENTAL
Intervention: 3D laparoscopy
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Laparoscopic simulation tasks
Number of subjects: 28
Study: 28092012

Group type: EXPERIMENTAL
Intervention: Telemedically supported case management
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard aftercare
Number of subjects: 46
Study: 25608520

Group type: EXPERIMENTAL
Intervention: HiBalance program (10-week duration)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 100
Study: 24093506

Group type: EXPERIMENTAL
Intervention: Augmented visual feedback balance training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional balance training according to physical therapy guidelines
Number of subjects: 0
Study: 21134035

Group type: EXPERIMENTAL
Intervention: Remote assessment using a novel optical imaging system with a three-dimensional camera and disposable optical marker.
Number of subjects: 20

Group type: COMPARATOR
Intervention: In-person assessment by clinicians.
Number of subjects: 20
Study: 19929994

Group type: EXPERIMENTAL
Intervention: Lispro mix 25 (LM25)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Glargine
Number of subjects: 480
Study: 16955767

Group type: EXPERIMENTAL
Intervention: Betnesol nasal drops in Mygind's position
Number of subjects: 23

Group type: COMPARATOR
Intervention: Betnesol nasal drops in LSHD position
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both positions (Mygind's and LSHD)
Number of subjects: 23
Study: 15026295

Group type: EXPERIMENTAL
Intervention: Medication adherence tracked with electronic cap monitors for 24 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conscientiousness and estimated IQ
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Depression and anxiety, mental flexibility, and visuospatial-constructional ability
Number of subjects: 0
Study: 10770980

Group type: EXPERIMENTAL
Intervention: High-fiber group (13.5 g per day of wheat-bran fiber)
Number of subjects: 1303

Group type: COMPARATOR
Intervention: Low-fiber group (2 g per day of wheat-bran fiber)
Number of subjects: 1303

Group type: EXPERIMENTAL
Intervention: High-fiber group
Number of subjects: 1303
Study: 9007490

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) 0.25 mg/kg/12 h
Number of subjects: 10
Study: 8024293

Group type: EXPERIMENTAL
Intervention: Topical inhaled corticosteroids (beclomethasone dipropionate 400 micrograms daily)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 3113712

Group type: EXPERIMENTAL
Intervention: Dibromomannitol (DBM) at a dose of 4 mg/kg
Number of subjects: 131

Group type: COMPARATOR
Intervention: Busulfan
Number of subjects: 131
Study: 30017217

Group type: EXPERIMENTAL
Intervention: Feedback (FB) group
Number of subjects: 163

Group type: COMPARATOR
Intervention: No Feedback (NFB) group
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 163
Study: 28374648

Group type: EXPERIMENTAL
Intervention: RUSF with 33% dairy protein
Number of subjects: 1272

Group type: COMPARATOR
Intervention: Control group (wait-listed to receive RUSF)
Number of subjects: 1272
Study: 25789868

Group type: EXPERIMENTAL
Intervention: Plasma adrenaline levels
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Serum sE-selectin levels
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Thrombomodulin levels
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Overall 180-day mortality
Number of subjects: 163
Study: 23028103

Group type: EXPERIMENTAL
Intervention: cinacalcet plus low‐dose vitamin D (≤ 6 µg/week of intravenous paricalcitol equivalent)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Vitamin D sterols alone
Number of subjects: 360
Study: 21939609

Group type: EXPERIMENTAL
Intervention: Web-based assessment after clinical assessment (group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Web-based assessment before clinical assessment (group B)
Number of subjects: 40
Study: 19043156

Group type: EXPERIMENTAL
Intervention: Phenylalanine-restricted diet
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 2000
Study: 16774847

Group type: EXPERIMENTAL
Intervention: Active monitoring (n=138)
Number of subjects: 318

Group type: COMPARATOR
Intervention: Self-selected treatment (n=180)
Number of subjects: 318
Study: 15003054

Group type: EXPERIMENTAL
Intervention: Functionally modulated Gaussian noise model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Scaling exponent of the correlation sum
Number of subjects: 0
Study: 11820714

Group type: EXPERIMENTAL
Intervention: Comprehensive outpatient GEMs program (N=79)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Usual care by family doctors (N=73)
Number of subjects: 152
Study: 9539495

Group type: EXPERIMENTAL
Intervention: Abciximab (GP IIb/IIIa blocker), administered as a bolus and 12-hour infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abciximab (GP IIb/IIIa blocker)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-dose, weight-adjusted heparin regimen, early vascular sheath removal, and elimination of routine postprocedural heparinization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abciximab (24-hour preprocedural infusion)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other GP IIb/IIIa inhibitors (eptifibatide, lamifiban, tirofiban)
Number of subjects: 0
Study: 8299787

Group type: EXPERIMENTAL
Intervention: One intrauterine insemination (IUI) timed 35 hours after ovulatory hCG (Group A)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Two intrauterine inseminations (IUI) performed 19 and 43 hours after hCG (Group B)
Number of subjects: 120
Study: 3405664

Group type: EXPERIMENTAL
Intervention: Phenobarbital receipt
Number of subjects: 232

Group type: COMPARATOR
Intervention: Control (no phenobarbital)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Presence of intraventricular hemorrhage
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Ecchymoses
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Birth weight less than 1.0 kg
Number of subjects: 232
Study: 31665455

Group type: EXPERIMENTAL
Intervention: Liraglutide (3 mg SQ daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 29568123

Group type: EXPERIMENTAL
Intervention: Intravenous anesthesia
Number of subjects: 208

Group type: COMPARATOR
Intervention: Volatile anesthesia
Number of subjects: 208
Study: 28069625

Group type: EXPERIMENTAL
Intervention: 6-hour group structured education programme with follow-up sessions
Number of subjects: 880

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 880
Study: 26806566

Group type: EXPERIMENTAL
Intervention: Music therapy (two sessions of live music-based relaxation exercises)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control (listened to a verbal relaxation exercise)
Number of subjects: 84
Study: 22842777

Group type: EXPERIMENTAL
Intervention: Supervised implementation of the Oral health care Guideline for Older people in Long‐term care Institutions (OGOLI)
Number of subjects: 342

Group type: COMPARATOR
Intervention: Non-supervised implementation (control group)
Number of subjects: 342
Study: 21418359

Group type: EXPERIMENTAL
Intervention: Mobilisation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bed Rest (Control)
Number of subjects: 100
Study: 18678572

Group type: EXPERIMENTAL
Intervention: Nurse-led support and education programme (six group meetings over six months)
Number of subjects: 100
Study: 16860028

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ) 12.5 mg
Number of subjects: 40
Study: 12701987

Group type: EXPERIMENTAL
Intervention: Synthetic formulation of BNP (nesiritide)
Number of subjects: 0
Study: 11045888

Group type: EXPERIMENTAL
Intervention: 100 mg sumatriptan orally at 0700 h
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100 mg sumatriptan orally at 0700 h and 0100 h
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100 mg sumatriptan orally at 1300 h
Number of subjects: 12
Study: 9075649

Group type: EXPERIMENTAL
Intervention: Interferon-alpha therapy
Number of subjects: 40
Study: 8370699

Group type: EXPERIMENTAL
Intervention: 0.5 g ethanol/kg wt
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 1 g ethanol/kg wt
Number of subjects: 9

Group type: COMPARATOR
Intervention: 0 g ethanol/kg wt
Number of subjects: 9
Study: 3522509

Group type: EXPERIMENTAL
Intervention: Piracetam (3300 mg daily for 12 weeks)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 31976701

Group type: EXPERIMENTAL
Intervention: Quantum states ρ_{1} and ρ_{2} prepared in separate experimental platforms
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Local measurements in randomized product bases
Number of subjects: 10
Study: 29917140

Group type: EXPERIMENTAL
Intervention: Sequential therapy of tamoxifen followed by exemestane
Number of subjects: 4631

Group type: COMPARATOR
Intervention: Exemestane monotherapy
Number of subjects: 4631
Study: 27793138

Group type: EXPERIMENTAL
Intervention: Fixed orthodontic appliances
Number of subjects: 108
Study: 24020828

Group type: EXPERIMENTAL
Intervention: Internet-based intervention programme (e-therapeutic platform) for 36 weeks (24 weeks of direct intervention and 12 weeks of follow-up)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment protocol
Number of subjects: 0
Study: 22534335

Group type: EXPERIMENTAL
Intervention: Lifestyle modifications (exercise and diet) for 4 months followed by gastric bypass
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (follow-up)
Number of subjects: 20
Study: 19409657

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole for 10 days
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo for 10 days
Number of subjects: 161
Study: 19176089

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTXA) injection into bilateral rectus muscle
Number of subjects: 60

Group type: COMPARATOR
Intervention: Surgery (recession of bilateral rectus muscle)
Number of subjects: 60
Study: 15849388

Group type: EXPERIMENTAL
Intervention: Thiopental
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 100
Study: 12807340

Group type: EXPERIMENTAL
Intervention: Hypericum cream (1.5% hyperforin)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Hypericum cream
Number of subjects: 21

Group type: COMPARATOR
Intervention: Hypericum cream and vehicle
Number of subjects: 21
Study: 10734287

Group type: EXPERIMENTAL
Intervention: Fludarabine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 1797617

Group type: EXPERIMENTAL
Intervention: Ultrasonography using a real time, B mode apparatus with a 3.5 MHz lineal transducer
Number of subjects: 3000
Study: 6314029

Group type: EXPERIMENTAL
Intervention: Bicarbonate dialysis (Bi HD)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Acetate dialysis (Ac HD)
Number of subjects: 10
Study: 30634036

Group type: EXPERIMENTAL
Intervention: clinic BPs
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: home BPs
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: kiosk BPs
Number of subjects: 510

Group type: COMPARATOR
Intervention: ABPM
Number of subjects: 510
Study: 29381793

Group type: EXPERIMENTAL
Intervention: 600 mg/d DHA
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo (corn and soybean oil)
Number of subjects: 154
Study: 26059084

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH) + aspirin (ASA)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Aspirin (ASA)
Number of subjects: 222
Study: 25212644

Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 3595

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3595
Study: 22374759

Group type: EXPERIMENTAL
Intervention: Pomegranate juice (8 oz/day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pomegranate juice
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Punicalagin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Apple juice (control)
Number of subjects: 12
Study: 20673325

Group type: EXPERIMENTAL
Intervention: EDUCORE method (visual learning method with SCORE scores and pamphlet)
Number of subjects: 736

Group type: COMPARATOR
Intervention: Normal clinical practice (control group)
Number of subjects: 736
Study: 17952272

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (G1) - 70.5 (45.1‐87.5) units of insulin/day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional treatment (G2) - 2 (0.6‐14.1) units of insulin/day
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (G1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional treatment (G2)
Number of subjects: 50
Study: 16365212

Group type: EXPERIMENTAL
Intervention: Diesel exhaust (300 microg/m3 particulate concentration)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Air (control)
Number of subjects: 30
Study: 12549734

Group type: EXPERIMENTAL
Intervention: Automated ECG artifact detection and elimination using the energy interval histogram method; applied to EEG recordings.
Number of subjects: 4
Study: 11092514

Group type: EXPERIMENTAL
Intervention: Wine consumption (190 mL red wine, 13% vol/vol ethanol, 5 days per week for 10 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Abstention from wine for 10 weeks
Number of subjects: 20
Study: 9094147

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (medicated patients with major affective disorder)
Number of subjects: 14